PL379465A1 - Preparat o przedłużonym uwalnianiu dla chlorowodorku wenlafaksyny - Google Patents

Preparat o przedłużonym uwalnianiu dla chlorowodorku wenlafaksyny

Info

Publication number: PL379465A1
Authority: PL; Poland
Prior art keywords: drug; formulation; functional; drug substance; sustained release
Prior art date: 2003-07-30

Application number

PL379465A

Other languages

English (en)

Other versions

PL207998B1 (pl

Inventor

Evangelos Karavas

Konstantinos Lioumis

Stavros Politis

Original Assignee

Pharmathen S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-07-30

Filing date

2004-07-23

Publication date

2006-09-18

2004-07-23 Application filed by Pharmathen S.A. filed Critical Pharmathen S.A.

2006-09-18 Publication of PL379465A1 publication Critical patent/PL379465A1/pl

2011-02-28 Publication of PL207998B1 publication Critical patent/PL207998B1/pl

Links

239000000203 mixture Substances 0.000 title abstract 4
238000009472 formulation Methods 0.000 title abstract 3
229960002416 venlafaxine hydrochloride Drugs 0.000 title 1
QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title 1
239000008186 active pharmaceutical agent Substances 0.000 abstract 4
229940088679 drug related substance Drugs 0.000 abstract 4
229940079593 drug Drugs 0.000 abstract 3
239000003814 drug Substances 0.000 abstract 3
238000013268 sustained release Methods 0.000 abstract 3
239000012730 sustained-release form Substances 0.000 abstract 3
229960004688 venlafaxine Drugs 0.000 abstract 3
PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 abstract 3
239000011247 coating layer Substances 0.000 abstract 2
239000000546 pharmaceutical excipient Substances 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
239000007963 capsule composition Substances 0.000 abstract 1
238000012377 drug delivery Methods 0.000 abstract 1
239000013583 drug formulation Substances 0.000 abstract 1
239000008185 minitablet Substances 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Emergency Medicine (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL379465A 2003-07-30 2004-07-23 Farmaceutyczna postać dawkowania o przedłużonym uwalnianiu chlorowodorku wenlafaksyny PL207998B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP03386019A EP1502587B1 (en)	2003-07-30	2003-07-30	Sustained release formulation for Venlafaxine hydrochloride

Publications (2)

Publication Number	Publication Date
PL379465A1 true PL379465A1 (pl)	2006-09-18
PL207998B1 PL207998B1 (pl)	2011-02-28

Family

ID=33522496

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL379465A PL207998B1 (pl)	2003-07-30	2004-07-23	Farmaceutyczna postać dawkowania o przedłużonym uwalnianiu chlorowodorku wenlafaksyny

Country Status (15)

Country	Link
US (2)	US20060182797A1 (pl)
EP (1)	EP1502587B1 (pl)
AT (1)	ATE336988T1 (pl)
AU (1)	AU2004258732B2 (pl)
BR (1)	BRPI0412354A (pl)
CA (1)	CA2529393C (pl)
CY (1)	CY1107576T1 (pl)
DE (1)	DE60307819T2 (pl)
DK (1)	DK1502587T3 (pl)
ES (1)	ES2271514T3 (pl)
PL (1)	PL207998B1 (pl)
PT (1)	PT1502587E (pl)
SI (1)	SI1502587T1 (pl)
WO (1)	WO2005009414A1 (pl)
ZA (1)	ZA200600790B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL146462A (en)	2001-11-13	2015-02-26	Lycored Bio Ltd	Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
CA2507685A1 (en) *	2002-11-28	2004-06-10	Themis Laboratories Private Limited	Process for manufacturing sustained release microbeads containing venlafaxine hci
WO2005048979A2 (en) *	2003-10-06	2005-06-02	Torrent Pharmaceuticals Limited	Pharmaceutical composition having casing with multiple micro tablets
DK1711169T3 (da) *	2004-02-04	2007-09-17	Alembic Ltd	Coatede mikrodepottabletter med venlafaxinhydrochlorid
WO2006136927A1 (en) *	2005-06-22	2006-12-28	Glenmark Pharmaceuticals Limited	Extended release formulations comprising venlafaxine
US8920837B2 (en) *	2005-07-01	2014-12-30	Rubicon Research Private Limited	Sustained release dosage form
US7427414B2 (en) *	2006-01-18	2008-09-23	Astron Research Limited	Modified release oral dosage form using co-polymer of polyvinyl acetate
US20090175934A1 (en) *	2006-03-08	2009-07-09	Jubilant Organosys Ltd.	Extended Release Pharmaceutical Formulation of Venlafaxine and Method of Manufacturing the Same
WO2007112574A1 (en) *	2006-04-03	2007-10-11	Isa Odidi	Extended release composition of venlafaxine
HUE029173T2 (hu)	2006-04-26	2017-02-28	Alphapharm Pty Ltd	Szabályozott hatóanyag-leadású készítmények, amelyek tartalmaznak nem bevont diszkrét egység(ek)et és egy késleltetett hatóanyag-leadású mátrixot
WO2008140461A1 (en) *	2007-05-16	2008-11-20	Fmc Corporation	Solid form
CA2702664A1 (en) *	2007-10-16	2009-04-23	Alphapharm Pty Ltd	Controlled-release pharmaceutical formulation
WO2010100657A2 (en) *	2009-03-04	2010-09-10	Fdc Limited	A novel oral controlled release dosage forms for water soluble drugs
US20130004563A1 (en) *	2011-06-07	2013-01-03	Shah Syed	Multiparticulate s-adenosylmethionine compositions and related methods
CN103948557A (zh) *	2014-04-08	2014-07-30	闻晓光	一种新型控释片

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE57198A1 (es)	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
US6274171B1 (en) *	1996-03-25	2001-08-14	American Home Products Corporation	Extended release formulation of venlafaxine hydrochloride
UA77145C2 (en) *	1997-11-05	2006-11-15	Wyeth Corp	Extended release dosage formulation
ES2290027T3 (es)	1999-05-20	2008-02-16	Elan Corporation, Plc	Formulaciones multiparticuladas y de liberacion controlada de inhibidores selectivos de la recaptacion de serotonina.
BR0100334A (pt)	2001-01-17	2002-09-24	Diffucap Chemobras Quimica E F	Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
AU2002248792B2 (en) *	2001-04-18	2006-09-21	Nostrum Pharmaceuticals Inc.	A novel coating for a sustained release pharmaceutical composition
CA2457385A1 (en) *	2001-08-06	2003-02-20	Dr. Reddy's Laboratories Ltd.	Improved enteric formulation of fluoxetin
AR039164A1 (es) *	2002-03-28	2005-02-09	Synthon Bv	Sales de venlafaxina de baja solubilidad en agua

2003
- 2003-07-30 EP EP03386019A patent/EP1502587B1/en not_active Expired - Lifetime
- 2003-07-30 ES ES03386019T patent/ES2271514T3/es not_active Expired - Lifetime
- 2003-07-30 PT PT03386019T patent/PT1502587E/pt unknown
- 2003-07-30 DE DE60307819T patent/DE60307819T2/de not_active Expired - Lifetime
- 2003-07-30 DK DK03386019T patent/DK1502587T3/da active
- 2003-07-30 AT AT03386019T patent/ATE336988T1/de active
- 2003-07-30 SI SI200330541T patent/SI1502587T1/sl unknown
2004
- 2004-07-23 WO PCT/GR2004/000039 patent/WO2005009414A1/en not_active Ceased
- 2004-07-23 US US10/565,322 patent/US20060182797A1/en not_active Abandoned
- 2004-07-23 PL PL379465A patent/PL207998B1/pl not_active IP Right Cessation
- 2004-07-23 CA CA2529393A patent/CA2529393C/en not_active Expired - Fee Related
- 2004-07-23 BR BRPI0412354-9A patent/BRPI0412354A/pt not_active IP Right Cessation
- 2004-07-23 AU AU2004258732A patent/AU2004258732B2/en not_active Ceased
2006
- 2006-01-27 ZA ZA200600790A patent/ZA200600790B/en unknown
- 2006-11-10 CY CY20061101625T patent/CY1107576T1/el unknown
2011
- 2011-03-23 US US13/069,795 patent/US20110171297A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BRPI0412354A (pt)	2006-09-05
AU2004258732B2 (en)	2009-06-11
US20110171297A1 (en)	2011-07-14
EP1502587B1 (en)	2006-08-23
ATE336988T1 (de)	2006-09-15
DE60307819T2 (de)	2007-10-04
DK1502587T3 (da)	2007-01-02
WO2005009414A1 (en)	2005-02-03
ES2271514T3 (es)	2007-04-16
CA2529393A1 (en)	2005-02-03
DE60307819D1 (de)	2006-10-05
CA2529393C (en)	2010-08-17
PL207998B1 (pl)	2011-02-28
EP1502587A1 (en)	2005-02-02
CY1107576T1 (el)	2013-03-13
SI1502587T1 (sl)	2007-02-28
PT1502587E (pt)	2007-01-31
ZA200600790B (en)	2007-04-25
US20060182797A1 (en)	2006-08-17
AU2004258732A1 (en)	2005-02-03

Legal Events

Date	Code	Title	Description
2014-08-29	LAPS	Decisions on the lapse of the protection rights	Effective date: 20130723

Publication	Publication Date	Title
SI1502587T1 (sl)	2007-02-28	Formulacija z zadrzevanim sproscanjem za Venlafaxin hidroklorid
AP1748A (en)	2007-06-11	Chronotherapeutic dosage forms.
WO2004026262A3 (en)	2004-06-10	Abuse-resistant pharmaceutical compositions
WO2004012699A3 (en)	2004-04-01	Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
WO2002028376A3 (en)	2003-03-06	Chrono delivery formulations and method of use thereof
WO2007103557A3 (en)	2008-11-20	Coating capsules with active pharmaceutical ingredients
CA2417686A1 (en)	2003-08-01	Manufacture of oral dosage forms delivering both immediate release and sustained release drugs
YU28104A (sh)	2006-08-17	Oralni oblici davanja propiverina ili njegovih farmaceutski prihvatljivih soli sa produženim oslobađanjem aktivne materije
HUP0203451A2 (hu)	2003-02-28	Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
CA2453263A1 (en)	2003-03-20	Pharmaceutical compositions containing terbinafine and use thereof
HUP0003405A2 (hu)	2001-02-28	Szabályozott hatóanyag-leadású, szublingvális vagy bukkális adagolású gyógyszerkészítmények
HUP0301887A2 (hu)	2003-09-29	Több részecskébżl álló gyógyszerforma, amely legalább két különbözżen bevont pelletformát tartalmaz
AU5680100A (en)	2001-01-02	Controlled release and taste masking oral pharmaceutical compositions
WO2005027843A3 (en)	2006-03-02	Chronotherapeutic dosage forms
CA2251886A1 (en)	1997-10-30	An oral pharmaceutical formulation containing ibandronate
CA2352211A1 (en)	2001-04-05	Sustained release matrix systems for highly soluble drugs
WO2007146293A3 (en)	2008-08-14	Improved composition and method for taste masking
ES2185452A1 (es)	2003-04-16	Composicion farmaceutica de fluoxetina en comprimido dispersable recubierto y su proceso de fabricacion.
JP2008543936A5 (pl)	2009-12-17
IL154731A0 (en)	2003-10-31	Ion-strength independent sustained release pharmaceutical formulation
EP2397122A3 (en)	2012-01-25	Formulations of neramexane dosage forms
CA2516327A1 (en)	2004-09-02	Therapeutic system comprising amoxicillin and clavulanic acid
WO2003045305A3 (en)	2003-11-13	Acetaminophen compositions
WO2006053089A3 (en)	2006-08-24	Methods and formulations for making pharmaceutical compositions containing bupropion
WO2002062299A3 (en)	2003-04-24	Improved controlled release oral dosage form